Økonomisk evaluering av helseintervensjonar

Konferanseforedrag

• Bjarne Robberstad; Kamija S. Phiri (2021). Symposium 3: Monthly malaria chemoprevention for the post-discharge management (PMC) of severe anaemia in children - Clinical evidence, effective implementation, acceptability, epidemiological consequences, cost-effectiveness and equity impact (introduction and overview). (ekstern lenke)
• Thandile Nkosi-Gondwe; Bjarne Robberstad; Mavuto Mukaka et al. (2021). Effectiveness of community versus facility delivery of dihydroartemisinin-peraquine for post-discharge malaria chemoprevention in management of severe anaemia in Malawian children. (ekstern lenke)
• Amani Thomas Mori; Lucy C Okell; Titus Kimutai Kwambai et al. (2021). Epidemiological impact of PMC. (ekstern lenke)
• Bjarne Robberstad; Yusuf Hemed; Ole Frithjof Norheim (2002). The cost-effectiveness of selected interventions targeting major source of burden of disease in Tanzania. (ekstern lenke)
• Bjarne Robberstad (2002). Antiretroviral treatment in low income settings: priority setting considerations. (ekstern lenke)
• Bjarne Robberstad; Ole Frithjof Norheim (2007). ART in Africa does not lead to improved equity in health. (ekstern lenke)
• Titus Kimutai Kwambai; Amani Thomas Mori; Sarah Nevitt et al. (2018). Post-discharge risks of morbidity and mortality in children in malaria endemic settings in Africa: A systematic review and meta-analysis - Oral presentation. (ekstern lenke)
• Bjarne Robberstad (2005). Applied economic evaluations and studies on time preferences for health in Tanzania. (ekstern lenke)
• Bjarne Robberstad (2004). Cost-effectiveness in Priority Setting. (ekstern lenke)
• Bjarne Robberstad (2004). Førebygging av hjarte-karsjukdom i u-land - fornuftig bruk av knappe helsebudsjett i samfunn med høg forekomst av HIV-AIDS?. (ekstern lenke)
• Titus Kimutai Kwambai; Dhabangi Aggrey; Richard Idro et al. (2017). CPD Migori: Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial.. (ekstern lenke)
• Titus Kimutai Kwambai; Dhabangi Aggrey; Richard Idro et al. (2017). Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial.. (ekstern lenke)
• Bjarne Robberstad; Ole Frithjof Norheim (2007). ART in Africa does not lead to improved equity in health. (ekstern lenke)

Vitenskapelig artikkel

• Thandile Gondwe; Bjarne Robberstad; Bjørn Blomberg et al. (2018). Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers’ perceptions and motivation. (ekstern lenke)
• Bjarne Robberstad; Jan Abel Olsen (2010). The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study. (ekstern lenke)
• Georg Ruhago; Frida Namnyak Ngalesoni; Bjarne Robberstad et al. (2015). Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania. (ekstern lenke)
• Hamidah Hussain; Amyn Malik; Junaid F. Ahmed et al. (2021). Cost-effectiveness of household contact investigation for detection of tuberculosis in Pakistan. (ekstern lenke)
• Bjarne Robberstad; Yusuf Hemed; Ole Frithjof Norheim (2007). Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country - the case of Tanzania. (ekstern lenke)
• Jobiba Joe Henderson Chinkhumba; Manuela De Allegri; Jacob Mazalale et al. (2017). Household costs and time to seek care for pregnancy related complications: The role of results-based financing. (ekstern lenke)
• Alemayehu Hailu; Bernt Lindtjorn; Wakgari Deressa et al. (2017). Economic burden of malaria and predictors of cost variability to rural households in southcentral Ethiopia. (ekstern lenke)
• Hamidad Farid Hussain; Amani Thomas Mori; Aamir Javed Khan et al. (2019). The cost-effectiveness of incentive-based active case finding for tuberculosis (TB) control in the private sector Karachi, Pakistan. (ekstern lenke)
• Carl Tollef Solberg; Mathias Barra; Bjarne Robberstad (2020). Should we discount future health benefits? Pro et contra (English translation). (ekstern lenke)
• Thandile Nkosi-Gondwe; Bjarne Robberstad; Robert Opoka et al. (2023). Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial. (ekstern lenke)
• Jobiba Joe Henderson Chinkhumba; Manuela De Allergi; Stephan Brenner et al. (2020). The cost-effectiveness of using results-based financing to reduce maternal and perinatal mortality in Malawi. (ekstern lenke)
• Admassu Nadew Lamu; Lars Björkman; Harald Johan Hamre et al. (2022). Is amalgam removal in patients with medically unexplained physical symptoms cost-effective? A prospective cohort and decision modelling study in Norway. (ekstern lenke)
• Lamprini Veneti; Bjarne Robberstad; Anneke Steens et al. (2024). Social contact patterns during the early COVID-19 pandemic in Norway: insights from a panel study, April to September 2020. (ekstern lenke)
• Sarah Svege; Siri Lange; Bjarne Robberstad et al. (2025). “I want to help my body”: Acceptability of malaria chemoprevention among children with sickle cell anaemia and their caregivers in Malawi and Uganda. (ekstern lenke)
• Alemayehu Hailu; Bernt Lindtjorn; Wakgari Deressa et al. (2018). Cost-effectiveness of a combined intervention of long lasting insecticidal nets and indoor residual spraying compared with each intervention alone for malaria prevention in Ethiopia. (ekstern lenke)
• Myness K. Ndambo; Kristine Bærøe; Kamija S. Phiri et al. (2025). Conceptualizing the implementation of post-discharge malaria chemoprevention in Malawi using a co-design approach. (ekstern lenke)
• Bjarne Robberstad; Carl Richard Frostad; Per Espen Akselsen et al. (2011). Economic evaluation of second generation pneumococcal vaccines in Norway. (ekstern lenke)
• Lucy C. Okell; Titus K. Kwambai; Aggrey Dhabangi et al. (2023). Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in Africa. (ekstern lenke)
• Victoria Nankabirwa; James K Tumwine; Olive Namugga et al. (2017). Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: Study protocol for a randomized controlled trial. (ekstern lenke)
• Asfaw Demissie Bikilla; Degu Jerene; Bjarne Robberstad et al. (2009). Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia. (ekstern lenke)
• Asfaw Demissie Bikilla; Degu Jerene; Bjarne Robberstad et al. (2009). Cost estimates of HIV care and treatment with and without anti-retrovira thereapy at Arba Minch Hospital in southern Ethiopia. (ekstern lenke)
• Eskindir Loha; Wakgari Deressa; Taye Gari Ayana et al. (2019). Long-lasting insecticidal nets and indoor residual spraying may not be sufficient to eliminate malaria in a low malaria incidence area: Results from a cluster randomized controlled trial in Ethiopia. (ekstern lenke)
• Janet Jull; Ian D. Graham; Elizabeth Kristjansson et al. (2019). Taking an integrated knowledge translation approach in research to develop the CONSORT-Equity 2017 reporting guideline: an observational study. (ekstern lenke)
• Alemayehu Hailu; Bernt Lindtjorn; Wakgari Deressa et al. (2016). Equity in long-lasting insecticidal nets and indoor residual spraying for malaria prevention in a rural South Central Ethiopia. (ekstern lenke)
• Amani Thomas Mori; Frida Namnyak Ngalesoni; Ole Frithjof Norheim et al. (2014). Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania. (ekstern lenke)
• Thandile Gondwe; Bjarne Robberstad; Mavuto Mukaka et al. (2021). Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial. (ekstern lenke)
• Peter Hangoma; Arild Aakvik; Bjarne Robberstad (2017). Explaining changes in child health inequality in the run up to the 2015 millennium development goals (MDGs): The case of Zambia. (ekstern lenke)
• Frida Ngalesoni; Georg Ruhago; Ole Frithjof Norheim et al. (2015). Economic cost of primary prevention of cardiovascular diseases in Tanzania. (ekstern lenke)
• Wakgari Deressa; Eskindir Loha; Meshesha Balkew et al. (2014). Combining long-lasting insecticidal nets and indoor residual spraying for malaria prevention in Ethiopia: study protocol for a cluster randomized controlled trial. (ekstern lenke)
• Admassu Nadew Lamu; Bjarne Robberstad; Harald Johan Hamre et al. (2021). Validity and responsiveness of GHC-index in patients with amalgam-attributed health complaints. (ekstern lenke)
• Carl Tollef Solberg; Mathias Barra; Bjarne Robberstad (2020). Bør vi diskontere fremtidige helsegevinster? Pro et contra. (ekstern lenke)
• Thandile Gondwe; Bjarne Robberstad; Mavuto Mukaka et al. (2018). Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial. (ekstern lenke)
• Admassu Nadew Lamu; Abdulrahman Jbaily; Stéphane Verguet et al. (2020). Is cycle network expansion cost-effective? A health economic evaluation of cycling in Oslo. (ekstern lenke)
• Titus Kimutai Kwambai; Aggrey Dhabangi; Richard Idro et al. (2018). Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: Study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial. (ekstern lenke)
• David Teigen; Robert O. Opoka; Phillip Kasirye et al. (2023). Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens. (ekstern lenke)
• Sarah Svege; Joseph Rujumba; Bjarne Robberstad et al. (2024). “Whatever is bad goes back to the woman”: The gendered blame game of sickle cell disease in Malawi and Uganda. (ekstern lenke)
• Bjarne Robberstad; Bjørg Evjen-Olsen (2010). Preventing Mother to Child Transmission of HIV With Highly Active Antiretroviral Treatment in Tanzania-a Prospective Cost-Effectiveness Study. (ekstern lenke)
• Ulrikke Højslev Lund; Anna Karina Stoinska-Schneider; Karianne Larsen et al. (2022). Cost-Effectiveness of Mobile Stroke Unit Care in Norway. (ekstern lenke)
• Lumbwe Chola; Lars T. Fadnes; Ingunn Marie S. Engebretsen et al. (2013). Infant feeding survival and Markov transition probabilities among children under age 6 months in Uganda. (ekstern lenke)
• Lumbwe Chola; Bjarne Robberstad (2009). Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia. (ekstern lenke)
• Janet E.G. Jull; Margaret Whitehead; Mark Petticrew et al. (2017). When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework. (ekstern lenke)
• Amani Thomas Mori; Paul Gavaza; Bjarne Robberstad (2013). Role of pharmacoeconomics in developing countries. (ekstern lenke)
• Martin N Mwangi; Glory Mzembe; Ernest Moya et al. (2021). Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trial. (ekstern lenke)
• Melf-Jakob Kühl; Thandile Gondwe; Aggrey Dhabangi et al. (2022). Economic evaluation of postdischarge malaria chemoprevention in preschool children treated for severe anaemia in Malawi, Kenya, and Uganda: A cost-effectiveness analysis. (ekstern lenke)
• Bjarne Robberstad (2005). QALYs vs DALYs vs LYs gained: What are the differences, and what difference do they make for health care priority setting. (ekstern lenke)
• Lumbwe Chola; Lungiswa Leonora Nkonki; Chipepo Kankasa et al. (2011). Cost of individual peer counselling for the promotion of exclusive breastfeeding in Uganda. (ekstern lenke)
• Anneke Steens; Birgitte Freiesleben De Blasio; Lamprini Veneti et al. (2020). Poor self-reported adherence to COVID-19-related quarantine/isolation requests, Norway, April to July 2020. (ekstern lenke)
• Jennifer Petkovic et al.; Janet Jull; Manosila Yoganathan et al. (2020). Reporting of health equity considerations in cluster and individually randomized trials. (ekstern lenke)
• Sarah Svege; Joseph Rujumba; Bjarne Robberstad et al. (2025). “Can you bury him before he dies?” Sickle cell disease and social sites of suffering in Malawi and Uganda. (ekstern lenke)
• Bjarne Robberstad; Ole Frithjof Norheim (2011). Incorporating concerns for equal lifetime health in evaluations of public health programs. (ekstern lenke)
• Lydia Kapiriri; Bjarne Robberstad; Ole Frithjof Norheim (2003). The relationship between prevention of mother to child transmission of HIV and stakeholder decision making in Uganda: Implications for health policy. (ekstern lenke)
• Shoaib Hassan; Tehmina Mustafa; William Muller et al. (2024). Comparing the cost-effectiveness of the MPT64-antigen detection test to Xpert MTB/RIF and ZN-microscopy for the diagnosis of Extrapulmonary Tuberculosis: An economic evaluation modelling study. (ekstern lenke)
• Wakgari Deressa; Eskindir Loha; Meshesha Balkew et al. (2016). Combining long-lasting insecticidal nets and indoor residual spraying for malaria prevention in Ethiopia: Study protocol for a cluster randomized controlled trial. (ekstern lenke)
• Kjell Arne Johansson; Bjarne Robberstad; Ole Frithjof Norheim (2010). Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy. (ekstern lenke)
• Jobiba Joe Henderson Chinkhumba; Manuela De Allegri; Adamson S. Muula et al. (2014). Maternal and perinatal mortality by place of delivery in sub-Saharan Africa: A meta-analysis of population-based cohort studies. (ekstern lenke)
• Peter John Binyaruka; Bjarne Robberstad; Gaute Torsvik et al. (2018). Does payment for performance increase performance inequalities across health providers? A case study of Tanzania. (ekstern lenke)
• Amani Thomas Mori; Mweetwa Mudenda; Bjarne Robberstad et al. (2024). Impact of cash transfer programs on healthcare utilization and catastrophic health expenditures in rural Zambia: a cluster randomized controlled trial. (ekstern lenke)
• Amani Thomas Mori; Linda Milimo Kampata; Patrick Musonda et al. (2017). Cost-benefit and extended cost-effectiveness analysis of a comprehensive adolescent pregnancy prevention program in Zambia: study protocol for a cluster randomized controlled trial. (ekstern lenke)

Fremhevet artikkel i media

• Bjarne Robberstad (2015). Alder og alvor :. (ekstern lenke)
• Bjarne Robberstad; Jan Erik Askildsen; Ole Frithjof Norheim (2013). Styrer budsjettkonsekvens norske refusjonsprioriteringar?. (ekstern lenke)

Doktorgradsavhandling

• Amani Thomas Mori; Bjarne Robberstad (2015). Pharmacoeconomics and Formulary Decision-Making in Tanzania. Generating Evidence for Antimalarial Drugs. (ekstern lenke)
• Peter Hangoma; Bjarne Robberstad; Arild Aakvik (2017). Social Protection, Health Risk, and Household Welfare in Zambia. (ekstern lenke)
• Peter John Binyaruka; Gaute Torsvik; Bjarne Robberstad (2018). Distributional effects of payment for performance in the health sector. Examining effects on structural quality, performance outcomes and service utilisation in Tanzania. (ekstern lenke)
• Bjarne Robberstad; Ole Frithjof Norheim; Gunnar Kvåle et al. (2005). Economic evaluation of health interventions in sub-Saharan Africa : applied economic evaluations and studies on time preferences for health in Tanzania. (ekstern lenke)
• Jobiba Joe Henderson Chinkhumba; Bjarne Robberstad (2018). Economic analysis of Results based financing in Malawi. Strengthening the evidence base for alternative maternal and perinatal Healthcare funding. (ekstern lenke)

Konferanseposter

• Melf-Jakob Kühl; Mehmajeet Kaur Pannu; Feiko ter Kuile et al. (2019). Predicting parents’ adherence to malaria prophylaxis: a multivariable prediction model for caregivers’ adherence to post-discharge malaria chemoprophylaxis for children in Malawi. (ekstern lenke)
• Thandile Gondwe; Bjarne Robberstad; Mavuto Mukaka et al. (2019). Effectiveness Of Community Versus Facility Delivery Strategies On Adherence To Dihydroartemesinin-Piperaquine For Post-Discharge Malaria Chemoprevention In Management Of Severe Anaemia In Malawian Children. (ekstern lenke)
• Thandile Gondwe; Bjarne Robberstad; Mavuto Mukaka et al. (2019). Effectiveness Of Community Versus Facility Delivery Strategies On Adherence To Dihydroartemesinin-Piperaquine For Post-Discharge Malaria Chemoprevention In Management Of Severe Anaemia In Malawian Children. (ekstern lenke)
• Titus Kimutai Kwambai; Dhabangi Aggrey; Richard Idro et al. (2017). Globvac: Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial.. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Amani Thomas Mori; Bjarne Robberstad (2012). Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review. (ekstern lenke)
• Kishan Kumar Chudasama; Kjetil Gundro Brurberg; Bjarne Robberstad et al. (2019). Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission. (ekstern lenke)
• Amani Thomas Mori; Peter Binyaruka; Peter Hangoma et al. (2020). Patient and health system costs of managing pregnancy and birth-related complications in sub-Saharan Africa: A systematic review. (ekstern lenke)

Forskningsrapport

• Bjarne Robberstad; Yusuf Hemed; Ole Frithjof Norheim (2004). Cost-effectiveness of Medical Interventions to Prevent Cardiovascular Disease in a sub-Saharan African Country - the case of Tanzania. (ekstern lenke)
• Bjarne Robberstad (2004). Estimation of Private and Social Time Preferences for Health in Northern Tanzania. (ekstern lenke)
• Line Holtet Evensen; Linn Kleven; Kristin Thuve Dahm et al. (2023). Sutur av degenerative rotatorcuff-rupturer: en fullstendig metodevurdering. (ekstern lenke)
• Ulrikke Højslev Lund; Julia Bidonde; Hege Kornør et al. (2021). Minimally Invasive Glaucoma Surgery (MIGS) for individuals with glaucoma. A health technology assessment. (ekstern lenke)
• Beate Charlotte Fagerlund; Anna Stoinska-Schneider; Vigdis Lauvrak et al. (2019). Health technology assessment of Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk – Part 2. Health economic evaluation. (ekstern lenke)
• Anna Stoinska-Schneider; Bjarne Robberstad; Brynjar Fure (2016). Mekanisk trombektomi ved akutt hjerneinfarkt del 2. Helseøkonomisk evaluering. (ekstern lenke)
• Beate Charlotte Fagerlund Kvist; Kishan Kumar Chudasama; Kjetil Gundro Brurberg et al. (2019). Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission. (ekstern lenke)
• Maria Julia Bidonde Torre; Beate Charlotte Fagerlund; Katrine Bjørnebek Frønsdal et al. (2017). FreeStyle Libre Flash Glucose Self‐Monitoring System: A Single‐Technology Assessment. (ekstern lenke)

Leserbrev

• Ingvild Fossgard Sandøy; Bente Elisabeth Moen; Simon Nygaard Øverland et al. (2024). Forskere føler seg lurt. (ekstern lenke)
• Bjarne Robberstad; Per Espen Akselsen; Kari Jorunn Kvaerner et al. (2013). Response to "Reply to: Economic evaluation of second generation pneumococcal conjugate vaccines in Norway". (ekstern lenke)
• Bjarne Robberstad (2015). B. Robberstad svarer :. (ekstern lenke)

Masteroppgave

• Yiga Dominic Bukenya; Bjarne Robberstad (2008). Impact of anti-retroviral therapy on sexual behaviour among Villa-Maria hospital clients, Masaka district Uganda. (ekstern lenke)
• Bjarne Robberstad; Lumbwe Chola (2008). The Economic Benefits of Breastfeeding: Estimating the Health System's Costs Associated with an Increased Prevalence of Exclusive Breastfeeding. (ekstern lenke)

Kapittel i fagbok

• Jan Van den Broeck; Lars Thore Fadnes; Bjarne Robberstad et al. (2013). Statistical Modeling. (ekstern lenke)
• Jan Van den Broeck; Jonathan R. Brestoff; Catherine Kaulfuss et al. (2013). Statistical Modeling. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin

Artiklar i fagfelleevaluerte tidsskrift

 

1. Mazalale, J., C Kambala, S Brenner, J Chinkhumba, J Lohmann, D Mathanga, B Robberstad, AS Muula and M de Allegri (2015). Factors associated with delivery outside a health facility: cross-sectional study in rural Malawi. Trop Med Int Health 20(5): 617-626.
2. Chola, L., LT Fadnes, IMS Engebretsen, L Nkonki, V Nankabirwa, H Sommerfelt, JK Tumwine, T Tylleskar and B Robberstad (2015). Cost-Effectiveness of Peer Counselling for the Promotion of Exclusive Breastfeeding in Uganda. PLoS One 10(11): e0142718.
3. Mori AT, Norheim OF, Robberstad B. Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania. Pharmacoeconomics 2015.
4. Wisloff, T. and B. Robberstad (2015). Re: Markov-modellering. Tidsskr Nor Laegeforen 135(16): 1432.
5. B Robberstad.  Alder og alvor (Age and severity of disease). Tidsskr Nor Laegeforen. 2015 Aug 11; 1376 – 1378.
6. Ruhago, GM, FN Ngalesoni, B Robberstad and OF Norheim. Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania. BMC Cost-Effectiveness and Resource Allocation 2015, 13:7. DOI: 10.1186/s12962-015-0033-0.
7. Chinkhumba J, M Allegri, AS Muula and B Robberstad. Maternal and perinatal mortality by place of delivery in sub-Saharan Africa: a meta-analysis of population-based cohort studies. BMC Public Health 2014, 14:1014  doi:10.1186/1471-2458-14-1014.
8. Deressa W, E Loha, M Balkew, A Desalegne, T Gari, T Gebremichael, O Kenea, D Jima, B Robberstad, HJ Overgaard and B Lindtjørn. Poster presentation: Combining long-lasting insecticidal nets and indoor residual spraying for malaria prevention in Ethiopia: study protocol for a cluster randomized controlled trial. Malaria Journal, 09/2014; 13(suppl 1): P25. DOI: 10.1186/1475-2875-13-S1-P25.
9. Mori AT, F Ngalesoni, OF Norheim and B Robberstad. Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania. Malaria Journal, 09/2014; 13(1):363. DOI: 10.1186/1475-2875-13-363.
10. Ngalesoni F, G Ruhago, OF Norheimand B Robberstad. Economic cost of primary prevention of cardiovascular diseases in Tanzania.  Health Policy Plan. (2014), doi: 10.1093/heapol/czu088.
11. Nkonki LL, E Daviaud, D Jackson, L Chola, T Doherty, M Chopra and B Robberstad. Costs of Promoting Exclusive Breastfeeding at Community Level in Three Sites in South Africa. PLOS One. 2014; Vol 9 (1); e79784.
12. Mori AT, EA Kaale, F Ngalesoni, OF Norheim and B Robberstad. The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Coutries: The Case of Tanzania. PLOS One. 2014; Vol 9 (1); e84824.
13. B Robberstad, JE Askildsen and OF Norheim. Styrer budsjettkonsekvens norske refusjonsprioriteringar? (Are reimbursement priorities guided by budget impact?). Tidsskr Nor Laegeforen. 2013 Sep 17;133(17):1841-3. doi: 10.4045/tidsskr.13.0215.
14. Olsen JA, Kristiansen IS, J Magnussen, OF Norheim, B Robberstad. Fagkritikkens utfordringer (The challenges of subject criticism). Tidsskr Nor Laegeforen. 2013 Mar 5;133(5):499. Doi: 10.4045/tidsskr.13.0174.
15. AT Mori, P Gavaza and B Robberstad.  Role of pharmacoeconomics in developing countries. Editorial. Farmeconomia. Health economics and therapeutic pathways 2013; 14(1)
16. B Robberstad, Akselsen PE, Kværner KJ and Berstad A. Response to Reply to Economic evaluation of second generation pneumococcal conjugate vaccines in Norway. Letter. Vaccine. 2013 Jan 7;31(3):442-3.
17. Chola L, LT Fadnes, IMS Engebretsen, T Tylleskar and B Robberstad. Infant feeding survival and Markov transition probabilities among children 0–6 months in Uganda. American Journal of Epidemiology. February 2013, DOI: 10.1093/aje/kws254.
18. Mori AT and B Robberstad.  Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review. BMC Medical Informatics and Decision Making. 2012;12: 110.
19. Robberstad B, CR Frostad, PE Akselsen, Kari J Kværner and Aud KH Berstad.  Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.  Vaccine 29 (2011): 8564-8574.
20. Chola L, L Nkonki, C Kankasa, J Nankunda, J Tumwine, T Tylleskar, B Robberstad, for the PROMISE-EBF Study Group. Cost of individual peer counselling for the promotion of exclusive breastfeeding in Uganda and Zambia.  Cost Effectiveness and Resource Allocation 2011, 9:11.
21. Robberstad B and OF Norheim.  Incorporating concerns for equal lifetime health in evaluations of public health programs.  Social Science & Medicine, Volume 72, Issue 10, May 2011, Pages 1711-1716.
22. Nkonki LL, M Chopra, T Doherty, D Jackson, B Robberstad. Explaining household socio economic-related child health inequalities using multiple methods in three diverse settings in South Africa.  International Journal for Equity in Health, April 2011.
23. Robberstad B and BE Olsen. Cost-effectiveness of prevention of mother to child transmission of HIV (PMTCTplus) at Haydom Hospital in Tanzania – a prospective cost-effectiveness study. J Acquir Immune Defic Syndr. Aug 24 2010.
24. Robberstad B and JA Olsen (2010). The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study. Cost Eff Resour Alloc 8: 5 (11 p).
25. Johansson, K A, B Robberstad and OF Norheim. (2010). "Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy." AIDS Research and Therapy 7(1): 3 (9 p).
26. Chola L and Robberstad B. Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia. Cost Effectiveness and Resource Allocation, 2009, 7:16 (8p).
27. Bikilla AD, D Jerene, B Robberstad and B Lindtjørn. Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia. Cost Effectiveness and Resource Allocation, 2009, 7:13 (11p).
28. Bikilla AD, D Jerene, B Robberstad and B Lindtjørn. Cost estimates of HIV care and treatment with and without anti-retrovira thereapy at Arba Minch Hospital in southern Ethiopia. Cost Effectiveness and Resource Allocation, 2009, 7:6 (7p).
29. Robberstad B, Y Hemed, and OF Norheim. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country - the case of Tanzania. Cost Effectiveness and Resource Allocation, 2007. 5: p. 3 (13p).
30. Robberstad B and Cairns J. Time preferences for health in northern Tanzania : an empirical analysis of alternative discounting models. Pharmacoeconomics, 2007. 25(1): p. 73-88.
31. Robberstad B. QALYs vs DALYs vs LYs gained:  What are the differences, and what difference do they make for health care priority setting?  Norwegian Epidemiology 2005; 15 (2): 183-191.
32. Wandwalo E, B Robberstad, O Morkve. Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania. Cost Effectiveness and Resource Allocation 2005;3:6. 
33. Robberstad B. Estimation of private and social time preferences for health in northern Tanzania.Social Science and Medicine 2005; 61(7):1597-607.
34. Robberstad B, T Strand, RE Black, H Sommerfelt. Cost-effectiveness of zinc as adjunct therapy for acute childhood diarrhoea in developing countries. Bulletin of the World Health Organization 2004;82(7):523-31.
35. Kapiriri L, B Robberstad and OF Norheim.  The Relationship between prevention of Mother to Child Transmission of HIV and Stakeholder Decision Making in Uganda:  Implications for Health Policy.  Health Policy, 66, 199-211, 2003.

 

 

 

                                             

Bøker og bokkapittel    

        

 

1. Jan vd Broeck, J Brestoff, C Kaulfuss and B Robberstad. Statistical Modeling (40 pages). In: Jan vd Broeck and Jonathan Brestoff (eds). Epidemiology – Principles and practical guidelines. Springer Verlag; DOI 10.1007/978-94-007-5989-3_10.
2. Jan vd Broeck, J Brestoff, A Friedman, N Becker, M Hoaglin and B Robberstad. The measurement plan (43 pages). In: Jan vd Broeck and Jonathan Brestoff (eds). Epidemiology – Principles and practical guidelines. Springer Verlag; DOI 10.1007/978-94-007-5989-3_10.
3. Sanders D, B Hutton, T Njamhanga, K Heggenhougen, G Kvåle and B Robberstad (editors). Globalization and Health. Copyright © 2012, University of the Western Cape, University of Bergen, Muhimbili University of Health and Allied Sciences.
4. Robberstad B andY Hemed: Economic Evaluation of Health Interventions: Tanzania Perspectives. In Handbook of Disease Burden. Edited by Preedy VA. Heidelberg: Springer Verlag; 2009:547-586.
5. B Robberstad: Economic evaluation of health interventions in sub-Saharan Africa. Applied economic evaluations and studies on time preferences for health in Tanzania. Thesis, submitted to University of Bergen, 2005.

 

 

 

 

 

 

 

1. Malaria Chemoprevention for the post-discharge management of severe anaemia in children in Malawi, Uganda and Kenya (IPTpd): Moving towards policy.  Budget 32.8 mill NOK, Research council of Norway, 2014-2019